# DROSPIRENONE
> **NDA216285** · New Drug Application · Sponsor: EXELTIS USA INC · Approved 2022-06-29
## Drug
- **FDA Application Number:** NDA216285
- **Application type:** New Drug Application
- **Brand name:** DROSPIRENONE
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE
- **Dosage form:** TABLET, CHEWABLE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** EXELTIS USA INC
- **First approval:** 2022-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216285)
---
*MORVS · CC0 1.0*